Bio-Rad Laboratories
(BIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 464,136 | 434,215 | 517,943 | 596,584 | 802,316 |
| Marketable Securities | 1,392,877 | 1,362,017 | 1,337,740 | 1,376,635 | 1,276,723 |
| Receivables | 498,273 | 494,645 | 432,302 | 450,324 | 464,107 |
| Inventories | 752,937 | 719,316 | 685,850 | 657,130 | 605,492 |
| Other current assets | 48,191 | 23,604 | 19,122 | 38,490 | 28,126 |
| TOTAL | $3,277,252 | $3,157,976 | $3,140,155 | $3,249,697 | $3,303,421 |
| Non-Current Assets | |||||
| PPE Net | 506,454 | 498,612 | 461,112 | 471,321 | 485,743 |
| Investments And Advances | 8,878,514 | 8,830,892 | 7,459,169 | 8,088,002 | 9,689,284 |
| Intangibles | 735,585 | 738,635 | 724,665 | 587,070 | 592,872 |
| Other Non-Current Assets | 269,607 | 275,551 | 273,361 | 286,037 | 302,381 |
| TOTAL | $10,390,160 | $10,343,690 | $8,918,307 | $9,432,430 | $11,070,280 |
| Total Assets | $13,667,410 | $13,501,670 | $12,058,460 | $12,682,130 | $14,373,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 519 | 465 | 448 | N/A | 504 |
| Accounts payable and accrued liabilities | 160,979 | 135,041 | 142,746 | 158,259 | 160,651 |
| Accrued Expenses | 173,913 | 194,790 | 192,460 | 180,631 | 184,542 |
| Other current liabilities | 167,196 | 169,648 | 171,706 | 212,715 | 211,586 |
| TOTAL | $589,623 | $568,708 | $570,677 | $613,714 | $648,331 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,198,005 | 1,197,716 | 1,197,272 | 1,196,943 | 1,196,739 |
| Other Non-Current Liabilities | 346,289 | 349,509 | 352,302 | 335,344 | 349,823 |
| TOTAL | $3,314,075 | $3,317,706 | $3,034,180 | $3,145,815 | $3,542,451 |
| Total Liabilities | $3,903,698 | $3,886,414 | $3,604,857 | $3,759,529 | $4,190,782 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,609 | 29,596 | 29,824 | 29,698 | 29,942 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | 9,966,959 | 9,898,203 | 9,046,530 | 9,210,457 | 10,137,630 |
| Other shareholders' equity | -408,648 | -466,408 | -845,475 | -533,726 | -308,144 |
| TOTAL | $9,763,716 | $9,615,252 | $8,453,605 | $8,922,597 | $10,182,920 |
| Total Liabilities And Equity | $13,667,414 | $13,501,666 | $12,058,462 | $12,682,126 | $14,373,702 |